Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | HRH2 | P25021 | 2/20 | 0.38 |
| ▸ | HRH1 | P35367 | 2/20 | 0.38 |
| ▸ | ARG1 | P05089 | 1/20 | 0.38 |
| ▸ | UBE2N | P61088 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6087667 | 1.00 | DPP4 (0.44) | DPP4DPP7DPP8DPP9SLC7A5 | |
| Valeric Acid SCHEMBL28795453 | 0.86 | HRH2 (0.43) | DPP4DPP7DPP8DPP9SLC7A5 | |
| SCHEMBL1707036 | 0.83 | DPP7 (0.51) | DPP4DPP7DPP8DPP9SLC7A5 | |
| SCHEMBL7817249 | 0.83 | DPP7 (0.51) | DPP4DPP7DPP8DPP9SLC7A5 | |
| SCHEMBL1707035 | 0.83 | DPP7 (0.51) | DPP4DPP7DPP8DPP9SLC7A5 | |
| SCHEMBL18774974 | 0.81 | MMP1 (0.51) | DPP4DPP7DPP8DPP9SLC7A5 | |
| Hydrochloric Acid SCHEMBL11172704 | 0.81 | DPP7 (0.50) | DPP4DPP7DPP8DPP9SLC7A5 | |
| SCHEMBL1622976 | 0.80 | MMP1 (0.40) | CA12CA1CA2CA9UBE2N | |
| SCHEMBL1622973 | 0.80 | MMP1 (0.40) | CA12CA1CA2CA9UBE2N | |
| SCHEMBL20413342 | 0.80 | DPP4 (0.45) | DPP4DPP7DPP8DPP9SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6982260-B1 | Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes | WARNER-LAMBERT COMPANY (US) | 2006-01-03 | — | — | US | disclosed |
| EP-1235815-A1 | QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES | WARNER-LAMBERT COMPANY (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-0877614-B1 | METHOD FOR INDUCING DEATH OF NEOPLASTIC CELLS USING PIPERAZINE OXIRANE DERIVATIVES | HITACHI CHEMICAL CO LTD (JP) | 2002-06-26 | — | — | EP | disclosed |
| WO-2001038315-A1 | QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES | WARNER-LAMBERT COMPANY (US) | 2001-05-31 | — | — | WO | disclosed |
| US-6054437-A | Method for inducing death of neoplastic cells using piperazine derivatives | HITACHI CHEMICAL RESEARCH CENTER, INC. (US) | 2000-04-25 | — | — | US | disclosed |
| US-5859013-A | ADMINISTERING TO TREAT MULTIDRUG RESISTANT CANCERS | HITACHI CHEMICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0877614-A1 | METHOD FOR INDUCING DEATH OF NEOPLASTIC CELLS USING PIPERAZINE OXIRANE DERIVATIVES | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1998-11-18 | — | — | EP | disclosed |
| US-5733911-A | ANTITUMOR AGENTS AND ANTICARCINOGENIC AGENTS | HITACHI CHEMICAL CO., LTD. (JP) | 1998-03-31 | — | — | US | disclosed |
| WO-1997026881-A1 | METHOD FOR INDUCING DEATH OF NEOPLASTIC CELLS USING PIPERAZINE OXIRANE DERIVATIVES | HITACHI CHEMICAL CO., LTD. (JP) | 1997-07-31 | — | — | WO | disclosed |
| US-4596803-A | Treating myocardial infarction | NIPPON CHEMIPHAR CO., LTD. (JP) | 1986-06-24 | — | — | US | disclosed |
| US-4507297-A | MYOCARDIAL INFARCTION | NIPPON CHEMIPHAR CO., LTD. (JP) | 1985-03-26 | — | — | US | disclosed |